The Daily

A rare moment where the policy fight is spelled out in plain language: the Pentagon is arguing that Anthropic could disable or alter its model behavior if it believes its internal “red lines” are being crossed during operations. That argument sits inside a 40‑page court filing as Anthropic seeks to block a “supply chain risk” designation. The backstory matters: Anthropic reportedly pushed back on uses like mass surveillance of Americans and the use of models in targeting/firing decisions for lethal weapons. Even if this ends as a contract dispute, it’s a preview of how “AI governance” becomes a battlefield claim.

More than a decade after the Fire Phone, Amazon is reportedly developing a new handset codenamed “Transformer” inside its Devices & Services org. The pitch isn’t “another phone,” it’s a front door for Amazon’s ecosystem (Shopping, Prime Video, Prime Music) with Alexa and AI features as the core interface. Reuters says the effort sits with ZeroOne, led by former Microsoft/Xbox exec J Allard. The strategic bet: if the assistant is the OS, owning the device matters again.

The “text‑to‑world” race keeps heating up. Edra says it raised a $30 million Series A to develop AI systems that generate interactive 3D scenes from natural language prompts — a step beyond static images into environments you can navigate. The obvious near‑term pull is games and prototyping, but the longer bet is workflow: rapid digital twins for design, training, and simulation. The hard part won’t be generation — it will be editing, physics, and consistency across sessions.

Novartis is paying $2B upfront (plus $1B in milestones) to acquire Synnovation’s PI3Kα program via its Pikavation subsidiary. The asset, SNV4818, is in phase 1/2 for PIK3CA‑mutated breast cancer and other solid tumors, with results expected in 2027. The rationale is less “new target” than better chemistry: mutant‑selective inhibitors that aim to spare wild‑type PI3K and improve tolerability vs today’s class toxicity. If it works, it fits neatly into combo regimens alongside endocrine therapy and CDK inhibitors.

Earendil Labs, described by Endpoints as China‑rooted and AI‑forward, has raised a massive $787 million round while floating the possibility of an IPO. The signal here isn’t just capital — it’s a willingness to fund AI‑enabled drug discovery at a scale that supports platform + pipeline simultaneously. In a market where many “AI biotechs” are still proving they can translate models into molecules, this is a bet on speed and volume. Watch for what they choose to advance: small molecules, biologics, or genuinely new modalities.

Veeva is paying around $100 million (cash plus long‑term retention equity) for Ostro, a 2019‑founded startup building conversational interfaces for pharma brand engagement. Ostro claims its tools are used by about half of the top 20 pharma companies, drawing responses from pre‑approved MLR materials to stay compliant. The practical implication: “AI in pharma” isn’t only R&D — the near‑term ROI may be in reducing friction for HCPs and patients trying to get answers. Expect more consolidation in this layer of the stack.

UCSF and collaborators report a two‑vector delivery system that can integrate a large DNA payload into human T cells in vivo at a specific locus — a step toward skipping the weeks‑long ex vivo manufacturing loop. The setup pairs an EDV (an enveloped delivery vehicle carrying Cas9 RNP, directed to T cells) with an evolved AAV capsid delivering the donor DNA. In mouse models, a single injection cleared aggressive leukemia within ~2 weeks and produced deep B‑cell aplasia; they also report surprising control of a solid tumor model. It’s early, but it reframes the access problem: CAR‑T as an injectable instead of a bespoke product.

This paper engineers inhalable iPSC‑derived exosomes displaying a bispecific PD‑1/mesothelin binder and loaded with indole‑3‑propionic acid to reprogram T‑cell metabolism. In an orthotopic lung cancer model, nebulized delivery achieved 79.3% tumor‑cell‑specific uptake (vs 47.9% for liposomes) and reduced tumor burden by 87.9%, with 80% survival at 80 days. Combined with CAR‑T, the regimen reached 66.7% complete remission and 100% survival at day 80, plus resistance to rechallenge in most mice. The implication is less “exosomes are magic” than “delivery + immune synapse design” can change the solid‑tumor math for CAR‑T.

Kurzliste: 95 Kunstschaffende · 14 Länder · 5.000+ Werke · Fixpreise · Eintritt frei Der Kunstsupermarkt ist eine dieser Wien‑Institutionen, die man leicht vergisst — bis man plötzlich ein Geschenk (oder ein Bild für die eigene Wand) braucht. Laut Wien.info läuft die 19. Saison bis 28. März 2026, gezeigt werden Zeichnungen, Aquarelle, Acryl‑ und Ölbilder, Fotoarbeiten und Kleinskulpturen. Die implizite Einladung: Kunstkauf ohne Galerien‑Ritual, dafür mit klaren Preisen.

Kurzliste: Skulpturendisplay (10–20h) · Pressekonferenz (12–13:30) · Film „IDP“ (18–19h) · Panel zu „Security Guarantees“ (19–20h) · Musikperformance (20:30) Am 10. März 2026 (freier Eintritt) macht das MQ den Wiener Hof zur Bühne für das öffentliche Programm des ukrainischen Pavillons der 61. Biennale di Venezia. Im Zentrum steht Zhanna Kadyrovas Skulptur „The Origami Deer“ (2019), deren Geschichte direkt in die Gegenwart führt: 2024 wurde sie aus Pokrowsk (Donezk) demontiert, als die Front näher rückte. Das ist Kulturprogramm mit echter politischer Schwerkraft — ohne PR‑Überhöhung.

Venice planning is now partly a climate and crowd‑management problem. Condé Nast Traveller frames it cleanly: the cheaper low season tends to be November to March, while peak pricing hits from spring to early autumn and spikes around major events like Carnival. The busiest tourist windows are typically April–June and September–October. If you’re optimizing for “Venice, but less brutal,” the shoulder months are still the sweet spot — just book early if you’re aligning with festivals.

Lonely Planet does something rare in travel writing: it puts numbers on the table. For high season, it lists reference costs like a €1.20 local transport ticket in Bari, €3 train Bari→Polignano a Mare, €1 coffee, and a seafood dinner for two at €50–70, with a budget‑traveler estimate around €117/day. The practical advice is equally concrete: fly into Bari/Brindisi on low‑cost carriers (watch baggage fees), use trains/buses, and lean on free beaches and picnics instead of lidos and sit‑downs. For anyone pricing out a spring/summer week, this is the kind of checklist that keeps Italy from quietly doubling in cost.

The NBA’s bracket tracker makes the calendar feel real: the SoFi Play‑In begins April 14, and the playoffs tip April 18. As of the March 17 games, the projected West matchups include Lakers vs Timberwolves (3–6) and Rockets vs Nuggets (4–5), with Suns vs Clippers penciled into the 7–8 Play‑In slot. In the East, the snapshot shows Knicks vs Magic (3–6) and Cavaliers vs Raptors (4–5), plus Heat/Hawks in the 7–8 Play‑In line. The bracket will churn, but the tension point is already set: every back‑to‑back matters.

Luka Doncic went nuclear in Miami: 60 points (18‑for‑30 FG, 9‑for‑17 from three, 15‑for‑19 FT) with 39 after halftime as the Lakers held off the Heat 134–126. LeBron James added a triple‑double (19/15/10) on the night he tied the NBA games‑played record, and LA’s streak hit eight. For Miami, Bam Adebayo scored 28, but the early 15‑point lead didn’t survive the third‑quarter swing. That’s a postseason‑type game in March — exactly the kind of pattern that defines seeding.

Kurzliste: City Farm Augarten (1020) · Waldseilpark Kahlenberg (ab 6.3.) · Dschungel Wien Workshops (MQ) · Motorikparks (Donaustadt/Favoriten) · Kurpark Oberlaa (Alpakas) Danach der pragmatische Teil: 1000things bündelt konkrete Ausflugs‑ und Aktivitätsideen mit Adressen und Öffnungs‑Hinweisen, statt nur „Frühling ist schön“ zu behaupten. Zwei harte Details, die man wirklich plant: Der Waldseilpark ist wieder offen März–Oktober und hat 17 Parcours; Kinder können ab 110 cm klettern (bis 14 mit Begleitperson). Genau solche Parameter retten Wochenenden.

Kurzliste: Dschungel Wien (MQ) · Urania Puppentheater (1010) · Marionettentheater Schönbrunn (1130) · Theater Heuschreck (1070) · Figurentheater Lilarum (1030) Mamilade ist hier weniger „News“ als ein sehr brauchbares Nachschlagewerk: wer spontan eine kindertaugliche Bühne sucht, bekommt eine kuratierte Liste mit Links und Bezirken. Für Familien heißt das: weniger Scroll‑Chaos, schneller entscheiden. Bonus: Im selben Umfeld tauchen saisonale Programmpunkte auf (z.B. Oster‑Programm im Kindermuseum Schönbrunn mit Zeitraum 21. März bis 6. April).